- 专利标题: Thia-triaza-indacenes
-
申请号: US13265241申请日: 2010-04-22
-
公开(公告)号: US09243000B2公开(公告)日: 2016-01-26
- 发明人: Lars Van Der Veen , Darryl McConnell , Siegfried Schneider , Matthias Grauert , Andreas Schoop , Tobias Wunberg
- 申请人: Lars Van Der Veen , Darryl McConnell , Siegfried Schneider , Matthias Grauert , Andreas Schoop , Tobias Wunberg
- 申请人地址: DE Ingelheim am Rhein
- 专利权人: Boehringer Ingelheim International GmbH
- 当前专利权人: Boehringer Ingelheim International GmbH
- 当前专利权人地址: DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Alan R. Stempel
- 优先权: EP09158494 20090422
- 国际申请: PCT/EP2010/055321 WO 20100422
- 国际公布: WO2010/122091 WO 20101028
- 主分类号: C07D513/04
- IPC分类号: C07D513/04 ; A61K31/381 ; C07D513/14
摘要:
The present invention encompasses compounds of general formula (1) wherein R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
公开/授权文献
- US20120108618A1 THIA-TRIAZA-INDACENES 公开/授权日:2012-05-03